Home › Amyloidosis › New Jersey
Amyloidosis clinical trials in New Jersey
4 studies for Amyloidosis are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- GSK Investigational Site, Hackensack
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07224672DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, New Brunswick
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07358078Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, New Brunswick
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Rutgers-Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.